share_log

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga ·  May 13 12:31

Gainers

  • CareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million.
  • Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.62. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday.
  • Macrogenics (NASDAQ:MGNX) stock rose 27.79% to $4.23. The market value of their outstanding shares is at $264.6 million. As per the news, the Q1 earnings report came out 2 days ago.
  • Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 25.68% to $2.3. The market value of their outstanding shares is at $13.5 million.
  • Omega Therapeutics (NASDAQ:OMGA) shares moved upwards by 24.01% to $2.43. The market value of their outstanding shares is at $134.0 million.
  • Titan Pharma (NASDAQ:TTNP) shares increased by 21.74% to $8.4. The market value of their outstanding shares is at $7.6 million.

Losers

  • TransCode Therapeutics (NASDAQ:RNAZ) shares declined by 40.1% to $0.84 during Monday's regular session. The company's market cap stands at $5.1 million.
  • Applied DNA Sciences (NASDAQ:APDN) stock fell 22.03% to $2.69. The market value of their outstanding shares is at $2.3 million. The company's, Q2 earnings came out yesterday.
  • Heart Test Laboratories (NASDAQ:HSCS) stock declined by 19.66% to $0.07. The company's market cap stands at $4.6 million.
  • Benitec Biopharma (NASDAQ:BNTC) shares decreased by 16.76% to $7.7. The market value of their outstanding shares is at $65.4 million. As per the press release, Q3 earnings came out today.
  • Oragenics (AMEX:OGEN) stock declined by 16.12% to $1.54. The market value of their outstanding shares is at $6.9 million.
  • Fortrea Holdings (NASDAQ:FTRE) shares declined by 15.78% to $27.82. The company's market cap stands at $2.4 billion. The company's, Q1 earnings came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment